(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

G. A. Ricaurte, L. S. Forno, M. A. Wilson, L. E. DeLanney, I. Irwin, M. E. Molliver and J. W. Langston
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.

(+/-)3,4-Methylenedioxymethamphetamine (MDMA) is a popular recreational drug that has been proposed to be useful as an adjunct to psychotherapy. This study assessed the neurotoxic potential of MDMA in nonhuman primates. Monkeys were repeatedly administered doses (2.50, 3.75, and 5.00 mg/kg) of MDMA subcutaneously and analyzed for regional brain content of serotonin and 5-hydroxyindoleacetic acid two weeks later. In all regions of the monkey brain examined, MDMA produced a selective dose-related depletion of serotonin and 5-hydroxyindoleacetic acid. These neurochemical deficits were associated with evidence of structural damage to serotonergic nerve fibers. In addition, MDMA produced pathological changes in nerve cell bodies in the dorsal, but not median, raphe nucleus. These results indicate that MDMA is a selective serotonergic neurotoxin in nonhuman primates and that humans using this drug may be at risk for incurring central serotonergic neuronal damage.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study
de Sola LLopis et al.
J Psychopharmacol 2008;22:498-510.
ABSTRACT  

Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria
Alves et al.
J. Neurosci. 2007;27:10203-10210.
ABSTRACT | FULL TEXT  

Electroconvulsive therapy in the treatment of depression in a former ecstasy user
Freudenmann et al.
J Psychopharmacol 2006;20:860-862.
ABSTRACT  

MDMA and Seizures: A Dangerous Liaison?
GIORGI et al.
Ann. N. Y. Acad. Sci. 2006;1074:357-364.
ABSTRACT | FULL TEXT  

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects
Reneman et al.
J Psychopharmacol 2006;20:164-175.
ABSTRACT  

Ecstasy: Are animal data consistent between species and can they translate to humans?
Easton and Marsden
J Psychopharmacol 2006;20:194-210.
ABSTRACT  

Pharmacological Characterization of Ecstasy Synthesis Byproducts with Recombinant Human Monoamine Transporters
Pifl et al.
J. Pharmacol. Exp. Ther. 2005;314:346-354.
ABSTRACT | FULL TEXT  

The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy")
Green et al.
Pharmacol. Rev. 2003;55:463-508.
ABSTRACT | FULL TEXT  

Reduced N-Acetylaspartate Levels in the Frontal Cortex of 3,4-Methylenedioxymethamphetamine (Ecstasy) Users: Preliminary Results
Reneman et al.
Am. J. Neuroradiol. 2002;23:231-237.
ABSTRACT | FULL TEXT  

Electrophysiological Evidence of Serotonergic Impairment in Long-Term MDMA (""Ecstasy"") Users
Croft et al.
Am. J. Psychiatry 2001;158:1687-1692.
ABSTRACT | FULL TEXT  

Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy"): Preliminary Findings
Reneman et al.
Arch Gen Psychiatry 2001;58:901-906.
ABSTRACT | FULL TEXT  

Effects of Ecstasy (MDMA) on the Brain in Abstinent Users: Initial Observations with Diffusion and Perfusion MR Imaging
Reneman et al.
Radiology 2001;220:611-617.
ABSTRACT | FULL TEXT  

Toxic Leukoencephalopathy
Filley and Kleinschmidt-DeMasters
NEJM 2001;345:425-432.
FULL TEXT  

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Gouzoulis-Mayfrank et al.
J. Neurol. Neurosurg. Psychiatry 2000;68:719-725.
ABSTRACT | FULL TEXT  

Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery
Hatzidimitriou et al.
J. Neurosci. 1999;19:5096-5107.
ABSTRACT | FULL TEXT  

Fatal multi-organ failure after suicidal overdose with MDMA, `Ecstasy': case report and review of the literature
Walubo and Seger
Hum Exp Toxicol 1999;18:119-125.
ABSTRACT  

REVIEW {blacksquare} : Long-lasting Effects of Recreational Drugs of Abuse on the Central Nervous System
McCann et al.
Neuroscientist 1997;3:399-411.
ABSTRACT  

MDMA (Ecstasy) and the Rave: A Review
Schwartz and Miller
Pediatrics 1997;100:705-708.
FULL TEXT  

Ecstasy and neurodegeneration
Green and Goodwin
BMJ 1996;312:1493-1494.
FULL TEXT  

Behavioural and neuroendocrine responses to D-fenfluramine in rats treated with neurotoxic amphetamines
Series et al.
J Psychopharmacol 1995;9:214-222.
ABSTRACT